Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Merck Gets a Breather -- for Now The beleaguered drug giant #39;s lowered forecast isn #39;t as bad as Wall Street expected. But investors still await the long-term prognosis.
